CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net income	$ 97,052	$ 92,138
Adjustments to reconcile net income to net cash provided from operating activities:
Deferred income tax expense	10,683	16,622
Depletion, depreciation and amortization	90,559	87,137
Abandonment and impairment of unproved properties	4,574	2,371
Derivative fair value loss (income)	158,957	(46,598)
Cash settlements on derivative financial instruments	4,573	122,373
Divestiture contract obligation, including accretion	8,897	10,267
Amortization of deferred financing costs and other	1,182	1,232
Deferred and stock-based compensation	15,083	18,215
Gain on the sale of assets	(62)	(87)
Gain on early extinguishment of debt	(3)	(64)
Changes in working capital:
Accounts receivable	(28,722)	107,454
Other current assets	(9,028)	(8,944)
Accounts payable	36,181	12,188
Accrued liabilities and other	(59,843)	(82,374)
Net cash provided from operating activities	330,083	331,930
Investing activities:
Additions to natural gas properties	(132,681)	(132,881)
Additions to field service assets	(722)	(1,003)
Acreage purchases	(24,919)	(21,714)
Proceeds from disposal of assets	50	31
Purchases of marketable securities held by the deferred compensation plan	(4,480)	(13,556)
Proceeds from the sales of marketable securities held by the deferred compensation plan	257	15,234
Net cash used in investing activities	(162,495)	(153,889)
Financing activities:
Repayment of senior notes	(2,157)	(14,975)
Dividends paid	(21,613)	(19,407)
Treasury stock purchases	(67,477)	0
Taxes paid for shares withheld	(21,238)	(24,214)
Change in cash overdrafts	(18,758)	10,003
Proceeds from the sales of common stock held by the deferred compensation plan	3,739	1,689
Net cash used in financing activities	(127,504)	(46,904)
Increase in cash and cash equivalents	40,084	131,137
Cash and cash equivalents at beginning of period	304,490	211,974
Cash and cash equivalents at end of period	$ 344,574	$ 343,111